Portland's Morant Gamble Is the Right Bet — But the Injury Clock Is Already Running

The Trail Blazers finished 43-40 last season, closed with three straight wins, and held opponents to 106.3 points per game over their final ten games — an 8-point defensive improvement from the prior 20-game stretch. That was a team discovering something real about itself. Then the front office decided that wasn't enough, and they were right. A 43-win team that needed Jrue Holiday to take 15.5 shots per game and shoot 39.4% to stay afloat in the final stretch is not a playoff team. It's a team that needs a primary creator. So Portland went and got one, trading Jerami Grant and Kris Murray to Memphis for Ja Morant. The move is correct. The timing is nerve-wracking.

Here is the narrow path to the good outcome: Morant arrives healthy, slides into the primary ball-handler role that Holiday was never built to carry at high volume, and immediately relieves the offensive burden that was breaking the system down the stretch. Holiday — who posted 6.0 assists per game and shot 44.8% from the field at his baseline — reverts to the secondary initiator and defensive anchor he has been throughout his career. Shaedon Sharpe, at 19.4 PPG on 45.1% shooting last season, becomes the movement scorer who feasts off Morant's gravity. Deni Avdija, the team's true engine at 23.7 PPG and 6.4 assists per game on 46.4% shooting across 76 games, operates as the versatile forward connector who makes all three guard options harder to guard. Robert Williams III, locked into a three-year extension and converting 68.5% of his field goal attempts, provides the rim-running anchor that keeps the paint honest. That is a functional, dangerous starting five. That is a playoff team in the West.

What breaks that path is the injury cloud that has hung over this offseason since late June. Morant was flagged as day-to-day as recently as July 18 — during summer league preparation, before a single training camp practice has been held. The exact nature of the issue hasn't been disclosed, and I won't speculate on severity. But Morant's medical history is not a secret: his career has been interrupted by significant time missed, and a team that just surrendered Grant's 17.9 points per game is not built to absorb another long absence from its new centerpiece. The margin for error is thin. Grant is gone. Kris Murray is gone. The forward depth behind Avdija and Toumani Camara — who logged 12.9 PPG and 5.1 rebounds across 89 games last season — is real but not star-level. If Morant misses meaningful time in 2026-27, Portland's offense reverts to the same Holiday-volume problem that cratered the efficiency numbers in April.

There is also a subtler roster question that the Morant acquisition doesn't fully answer: who guards the opponent's best wing? Matisse Thybulle, a two-time All-Defensive Team selection who spent last season in Portland, has since signed with the Lakers. His departure quietly removes a defensive specialist from a team that was just beginning to figure out how to defend at a high level. Camara can guard multiple positions and is a legitimate plus defender, but the Blazers are now a backcourt-heavy team — Morant, Holiday, and Sharpe — and backcourt-heavy teams get hunted on switches. The late-season defensive improvement was genuine, but it needs personnel to sustain it, and the roster construction leans offensive.

My read is this: Portland made the right trade. A healthy Ja Morant paired with Avdija's playmaking and Williams's rim protection is the kind of core that can win 50 games and compete in a playoff series. The bet is worth making. But the Blazers need Morant on the floor in October, not rehabbing through November. Every day between now and training camp that his status remains uncertain is a day the upside scenario gets harder to reach. The receipt on this optimism is simple: Morant healthy, Holiday in his role, Avdija as the connective tissue. If that holds, Portland is a genuine threat. If it doesn't, they've traded a reliable 18-point scorer for a